David Reese

Track

Insider profile

Currently holds a position at Amgen Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President - Research and Development Amgen Inc July 26, 2018 -
David Reese's trades of Amgen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
286.02
Quantity 15,569
Value US$4,758,887
US Amgen Inc (AMGN)
Transaction date
Sale
Price
63.27
Quantity 98,610 +15.2%
Value US$4,079,570
US Amgen Inc (AMGN)
Transaction date
Sale
Price
365.37
Quantity 15,829 +33.9%
Value US$4,257,256
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
293.22
Quantity 8,711
Value US$2,554,224
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-21 2025-02-21
US Amgen Inc (AMGN)
PrS Proposed sale
15,569
286.02
US$4,758,887 		15,569 286.02 US$4,758,887
2025-02-21 2025-02-21
US Amgen Inc (AMGN)
S Sale
98,610 +15.2%
63.27
US$4,079,570 		98,610 +15.2% 63.27 US$4,079,570
2025-02-21 2025-02-19
US Amgen Inc (AMGN)
S Sale
15,829 +33.9%
365.37
US$4,257,256 		15,829 +33.9% 365.37 US$4,257,256
2025-02-19 2025-02-19
US Amgen Inc (AMGN)
PrS Proposed sale
8,711
293.22
US$2,554,224 		8,711 293.22 US$2,554,224